| Literature DB >> 2323603 |
R J Playford1, C H Matthews, M J Campbell, H T Delves, K K Hla, H J Hodgson, J Calam.
Abstract
A 68 year old man with a creatinine clearance rate of only 15 ml/min took twice the recommended dose of tripotassium dicitrato bismuthate (TDB) as DeNol liquid; 10 ml qds; a total of 864 mg bismuth daily for two months. Whole blood bismuth concentrations rose to 880 micrograms/l and he developed global cerebral dysfunction with hallucinations, ataxia, and an abnormal EEG. Renal clearance of bismuth rose from 0.24 to 2.4 ml/min when the heavy metal chelator 2-3 dimercapto-1 propane sulphonic acid (DMPS) was given by mouth. Bismuth was measured by a novel method involving inductively coupled plasma source mass spectrometry. Fifty days after stopping TDB, whole blood bismuth concentrations fell to 46 micrograms/l and the patient's EEG returned to normal. His mental function also recovered completely. The case serves as a timely reminder that TDB should not be administered to patients with renal disorders, as stated in the data sheet.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2323603 PMCID： PMC1378285 DOI： 10.1136/gut.31.3.359
Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059